CN Patent

CN110269857A — 含阿维巴坦的抗菌组合物及其用途

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2019-09-24 · 7y expired

What this patent protects

本发明属于医药技术领域，涉及一种含阿维巴坦的抗菌组合物及其用途，具体而言，本发明提供了阿维巴坦或其药学上可接受的盐和碳青霉烯类抗生素在制备治疗或预防细菌感染的药物中的用途，特别是制备治疗大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌、鲍曼不动杆菌和产气肠杆菌引起感染的药物中的用途，以解决碳青酶烯类抗生素的耐药问题。

USPTO Abstract

本发明属于医药技术领域，涉及一种含阿维巴坦的抗菌组合物及其用途，具体而言，本发明提供了阿维巴坦或其药学上可接受的盐和碳青霉烯类抗生素在制备治疗或预防细菌感染的药物中的用途，特别是制备治疗大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌、鲍曼不动杆菌和产气肠杆菌引起感染的药物中的用途，以解决碳青酶烯类抗生素的耐药问题。

Drugs covered by this patent

Patent Metadata

Patent number
CN110269857A
Jurisdiction
CN
Classification
—
Expires
2019-09-24
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.